Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-05-15
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$648.1m
reported value
31positions
69.9%in top 10
—no comparable previous quarter
Holdings, Q3 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| TRICIDA INC TCDA | $94.8m14.63% | — |
| ACLARIS THERAPEUTICS INC ACRS | $71.8m11.08% | — |
| COGENT BIOSCIENCES INC COGT | $60.2m9.30% | — |
| RELMADA THERAPEUTICS INC RLMD | $56.2m8.67% | — |
| VIRIDIAN THERAPEUTICS INC VRDN | $43.7m6.74% | — |
| GH RESEARCH PLC GHRS | $38.7m5.98% | — |
| PLIANT THERAPEUTICS INC PLRX | $22.6m3.48% | — |
| MILESTONE PHARMACEUTICALS IN MIST | $22.3m3.44% | — |
| TERNS PHARMACEUTICALS INC COM | $21.8m3.37% | — |
| MARINUS PHARMACEUTICALS INC MRNS | $21.0m3.24% | — |
| GOSSAMER BIO INC GOSS | $20.9m3.23% | — |
| ANNEXON INC ANNX | $19.9m3.07% | — |
| INSTIL BIO INC COM | $19.9m3.07% | — |
| AKOUOS INC COM | $18.9m2.92% | — |
| DICE THERAPEUTICS INC COM | $15.5m2.39% | — |
| AEROVATE THERAPEUTICS INC COM | $13.8m2.13% | — |
| LIANBIO LIANY | $10.8m1.66% | — |
| FULCRUM THERAPEUTICS INC FULC | $9.7m1.50% | — |
| INOZYME PHARMA INC COM | $7.3m1.12% | — |
| VENTYX BIOSCIENCES INC VTYX | $7.3m1.12% | — |
| PROMETHEUS BIOSCIENCES INC COM | $7.2m1.11% | — |
| SAVARA INC SVRA | $7.1m1.09% | — |
| PROVENTION BIO INC PRVB | $5.0m0.78% | — |
| ALTIMMUNE INC ALT | $4.7m0.73% | — |
| TREVI THERAPEUTICS INC TRVI | $4.7m0.72% | — |
| LYRA THERAPEUTICS INC LYRA | $4.6m0.71% | — |
| IMMUNOCORE HLDGS PLC IMCR | $4.4m0.69% | — |
| ATYR PHARMA INC ATYR | $4.2m0.65% | — |
| RALLYBIO CORP COM | $3.9m0.60% | — |
| AFFIMED N V COM | $2.9m0.45% | — |
| CELLDEX THERAPEUTICS INC NEW CLDX | $2.1m0.33% | — |